We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$282M
AUM Growth
+$101M
Cap. Flow
+$95.9M
Cap. Flow %
34.02%
Top 10 Hldgs %
84.41%
Holding
86
New
17
Increased
41
Reduced
2
Closed
25

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$20.2M
2
AVP
Avon Products, Inc.
AVP
+$17.1M
3
STNE icon
StoneCo
STNE
+$16.1M
4
MELI icon
Mercado Libre
MELI
+$2.06M
5
MSCI icon
MSCI
MSCI
+$1.42M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.12%
2 Consumer Staples 10.76%
3 Healthcare 9.06%
4 Technology 8.82%
5 Financials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PARA
26
DELISTED
Paramount Global Class B
PARA
$947K 0.34%
+22,565
New +$874K
ACAD icon
27
Acadia Pharmaceuticals
ACAD
$5.03B
$940K 0.33%
21,963
+167
+0.8% +$7.26K
ONC
28
BeOne Medicines Ltd
ONC
$39.4B
$937K 0.33%
5,653
+68
+1% +$11.3K
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
$816K 0.29%
7,549
+84
+1% +$8.98K
ELV icon
30
Elevance Health
ELV
$85.5B
$748K 0.27%
2,476
+30
+1% +$8.26K
SYK icon
31
Stryker
SYK
$130B
$734K 0.26%
3,495
+42
+1% +$8.72K
MDLZ icon
32
Mondelez International
MDLZ
$79.9B
$729K 0.26%
13,243
+2,595
+24% +$139K
CI icon
33
Cigna
CI
$74.6B
$682K 0.24%
3,334
+40
+1% +$7.33K
PFE icon
34
Pfizer
PFE
$153B
$636K 0.23%
17,102
+206
+1% +$7.34K
A icon
35
Agilent Technologies
A
$41.2B
$590K 0.21%
6,921
+83
+1% +$6.53K
DHR icon
36
Danaher
DHR
$144B
$578K 0.21%
4,245
+51
+1% +$6.45K
AMRN
37
Amarin Corp
AMRN
$303M
$541K 0.19%
1,261
+15
+1% +$5.7K
LLY icon
38
Eli Lilly
LLY
$1.06T
$537K 0.19%
4,085
+49
+1% +$5.68K
HCA icon
39
HCA Healthcare
HCA
$89.5B
$507K 0.18%
3,428
+41
+1% +$5.51K
ASND icon
40
Ascendis Pharma A/S
ASND
$16.8B
$474K 0.17%
3,405
+45
+1% +$5K
BMRN icon
41
BioMarin Pharmaceuticals
BMRN
$12.4B
$468K 0.17%
5,538
+60
+1% +$4.53K
HUM icon
42
Humana
HUM
$46.2B
$423K 0.15%
1,155
+14
+1% +$4.44K
BMY icon
43
Bristol-Myers Squibb
BMY
$132B
$421K 0.15%
+6,560
New +$376K
CNC icon
44
Centene
CNC
$32.5B
$405K 0.14%
6,445
+78
+1% +$4.23K
REGN icon
45
Regeneron Pharmaceuticals
REGN
$80.8B
$385K 0.14%
1,025
+12
+1% +$4.04K
AZN icon
46
AstraZeneca
AZN
$250B
$383K 0.14%
3,839
+46
+1% +$4.33K
MRK icon
47
Merck
MRK
$318B
$382K 0.14%
4,401
+54
+1% +$4.43K
EXAS
48
DELISTED
Exact Sciences
EXAS
$341K 0.12%
+3,692
New +$325K
NBIX icon
49
Neurocrine Biosciences
NBIX
$16.6B
$337K 0.12%
3,134
+37
+1% +$3.87K
HOLX
50
DELISTED
Hologic
HOLX
$320K 0.11%
6,133
+74
+1% +$3.68K

Similar funds

JGP Global Gestao de Recursos's Q4 2019 Portfolio in Review

As of Q4 2019, JGP Global Gestao de Recursos held 86 positions worth $282M, up 56% from $181M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

JGP Global Gestao de Recursos deployed $95.9M of net new capital in Q4 2019, opening 17 new positions and adding to 41 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 1,500,000 shares worth $43.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was Mercado Libre, an estimated $2.06M trimmed.

  • JGP Global Gestao de Recursos's largest Q4 2019 buy was VanEck Gold Miners ETF: 1,500,000 shares worth $43.9M.
  • JGP Global Gestao de Recursos added most to iShares MSCI Emerging Markets ETF in Q4 2019, an estimated $30.9M increase.
  • JGP Global Gestao de Recursos's biggest Q4 2019 reduction was Mercado Libre, cutting an estimated $2.06M.
  • JGP Global Gestao de Recursos fully exited Wells Fargo in Q4 2019, selling an estimated $20.2M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 84% of its $282M portfolio in Q4 2019.
  • JGP Global Gestao de Recursos opened 17 new positions and closed 25 in Q4 2019.
  • JGP Global Gestao de Recursos's portfolio value rose 56% quarter-over-quarter to $282M.

Based on JGP Global Gestao de Recursos's 13F filing for Q4 2019, filed 24 Jan 2020.